First AD

Second AD

Lana Pine is the editor of HCPLive Rheumatology. She is an experienced editor and technical writer with a demonstrated history of working in the banking and publishing industries. In her free time, she enjoys cooking, yoga, listening to podcasts, and drawing. She can be reached via email at LPine@mjhlifesciences.com.

 is the ability to understand the disease and deal with the practical, physical and psychological impacts that come along with it

 is a multicomponent complex intervention

 Combination of methotrexate plus a non–TNF inhibitor

 Combination of methotrexate plus tsDMARDs

 Patients who have not been previously treated with either biologic disease-modifying antirheumatic drugs (DMARDs) or targeted synthetic DMARDs

 Patients who have had an inadequate response to biologic DMARDs or targeted synthetic DMARDs

 All patients with early or established rheumatoid arthritis

Rheumatology

Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.

Rheumatoid arthritis is a complex condition. How much do you know about RA treatment? 

Rheumatoid Arthritis Quiz: RA Treatment